GlassScriptPhysician profile
Reed B Graham
NPI 1114915931
$1,811.55
in general payments reported to CMS, 2019-2025
19 companies · $273 in 2025
The $273 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $682 · 2020: $171 · 2021: $160 · 2022: $424 · 2023: $101 · 2025: $273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $374.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $374.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $283.32 | 2019-2023 | Grafix Pl |
| Organogenesis INC. | $260.98 | 2019-2022 | |
| Integra Lifesciences Corporation | $212.06 | 2019-2022 | |
| Bioventus LLC | $148.18 | 2025 | Exogen Ultrasound Bone Healing System |
| Convatec INC. | $134.76 | 2019-2021 | |
| Stryker Corporation | $134.33 | 2019-2022 | |
| Polarityte, INC. | $106.46 | 2019 | |
| Horizon Therapeutics Plc | $97.82 | 2021-2022 | |
| Misonix INC | $86.75 | 2020 | |
| Zimmer Biomet Holdings, INC. | $68.38 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $58.94 | 2025 | |
| Depuy Synthes Sales INC. | $55.31 | 2022-2025 | Monovisc |
| Pacira Pharmaceuticals Incorporated | $42.35 | 2023-2025 | Iovera, Exparel, Zilretta |
| Paragon 28, INC. | $29.49 | 2020-2021 | |
| Rock Medical Orthopedics, INC. | $27.91 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $19.83 | 2019 | |
| Ferring Pharmaceuticals INC. | $17.97 | 2025 | Euflexxa |
| Merck Sharp & Dohme LLC | $13.69 | 2019 | |
| Orthofix Medical, INC. | $13.02 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reed Graham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.